AI-generated summary
The authors report a multicenter prospective study of 100 patients with mild-to-moderate melasma treated with a new cosmetic product containing kojic acid. Melasma severity scores on the modified melasma area and severity index fell at 45 and 90 days, and the authors say the treatment was associated with improvement. The study had no control group mentioned in the abstract, so the results cannot be attributed to the product alone.
- Participants
- 100
- Who or what was studied
- 100 patients with mild-to-moderate melasma, mostly female and Caucasian, mean age 45.19 years, recruited across 20 dermatology clinics
- Limits stated in the abstract
- The abstract reports no control group, and the authors do not describe the product's exact composition or any blinding.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.